Human placental lactogen
chorionic somatomammotropin hormone 1 (human placental lactogen) | |||||||
---|---|---|---|---|---|---|---|
Chr. 17 q22-q24 | |||||||
|
chorionic somatomammotropin hormone 2 | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | CSH2 | ||||||
Chr. 17 q22-q24 | |||||||
|
Human placental lactogen (hPL), also called human chorionic somatomammotropin (hCS) or human chorionic somatotropin, is a
Structure
hPL
Levels
hPL is present only during pregnancy, with maternal serum levels rising in relation to the growth of the fetus and placenta. Maximum levels are reached near term, typically to 5–7 mg/L.
Physiologic function
hPL affects the metabolic system of the maternal organism in the following manners:
- In a bioassay, hPL mimics the action of prolactin, yet it is unclear whether hPL has any role in human lactation.
- Metabolic:
- ↓ maternal blood glucose levels.
- ↓ maternal glucose utilization, which helps ensure adequate fetal nutrition (the mother responds by increasing beta cells). Chronic hypoglycemia leads to a rise in hPL.
- ↑ free fatty acids. With fasting and release of hPL, free fatty acids become available for the mother as free fatty acids do not cross the placenta, so that relatively more glucose can be utilized by the fetus. With sustained fasting, maternal ketones formed from free fatty acids can cross the placentaand be used by the fetus.
- ↓ maternal
These functions help support fetal nutrition even in the case of maternal malnutrition.
hPL is a potent agonist of the prolactin receptor and a weak agonist of the growth hormone receptor.[5]
Prolactin-like activity
hPL has been found to bind to the prolactin receptor with equal
Growth hormone-like activity
hPL has weak actions, similar to those of growth hormone, causing the formation of protein tissues in the same way that growth hormone, but 100 times more hPL than growth hormone is required to promote growth.[7] However, hPL has a blood level of more than 50 times that of hGH,[8] hence its effects must not be ignored. An enhancer for the human placental lactogen gene is found 2 kb downstream of the gene and participates in the cell-specific control gene expression.[citation needed]
Clinical measurement
While hPL has been used as an indicator of fetal well-being and growth, other
See also
- Placental lactogen in other species
- Somatotropin family
References
- ^ PMID 16546209.
- PMID 14068826.
- PMID 10841628. Retrieved 2018-03-23.
- PMID 36157466.
- ISBN 978-0-323-32195-2.
- ^ ISBN 978-1-4613-3688-4.
- ISBN 81-8147-920-3.in the same way that growth hormone.
This hormone has weak actions similar to those of growth hormone, causing the formation of protein tissues
- ^ "Growth Hormone: Reference Range, Interpretation, Collection and Panels". 2016-06-01.
{{cite journal}}
: Cite journal requires|journal=
(help)
- "RCSB Protein Data Bank - Structure Summary for 1Z7C - Crystal Structure of Human Placental Lactogen".
- "Human Chorionic Somatomammotropin Enhancer Function Is Mediated by Cooperative Binding of TEF-1 and CSEF-1 to Multiple, Low-Affinity Binding Sites". Archived from the original on 2008-07-05.
Further reading
- Speroff L, Glass RH, Kase NG (1999). Clinical gynecologic endocrinology and infertility (Sixth ed.). Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-683-30379-1.
External links
- Human+Placental+Lactogen at the U.S. National Library of Medicine Medical Subject Headings (MeSH)